KALV: KalVista Pharmaceuticals, Inc. Company Cash Volume

Corporate emblem and logo of KalVista Pharmaceuticals (KALV)

Currently in the clinical testing phase, KalVista Pharmaceuticals (KALV) incurs significant R&D expenses, which temporarily limits margins. KalVista Pharmaceuticals (KALV) is developing unique oral inhibitors for the therapy of rare pathologies, replacing injections with tablets. The company's cash position reflects its actual resilience to shocks, where 0.27 expresses the current value of the metric. The strategy is based on capturing the HAE market by improving patient comfort.

Company Liquid Assets: KalVista Corp (KALV) for 07/04/2022 - 06/21/2026

Analytical breakdowns for KalVista Pharmaceuticals

- current price and projected stock value:
Fundamental valuation:KALV KalVista Pharmaceuticals Inc
Brand item of KalVista Pharma

KalVista Pharmaceuticals (KALV) preparation for the market launch of its flagship drug requires strict liquidity control, meaning that daily monitoring of the company's cash reserves allows for an accurate assessment of the balance sheet's financial resilience. This metric captures the actual cash balance, where steady growth confirms the absence of credit risks, while excessive accumulation may signal inefficient capital management.

Competitor analysis for KalVista Pharmaceuticals

Company Cash Volume ARGX|BioNTech - Company Cash and Cash Equivalents|Company Cash Volume ABVX (abivax.com)|Company Cash Balance ADMA|Protagonist Therapeutics, Inc. - Company Cash Volume|Company Cash Reserve Immunovant, Inc.|KNSA: Company Cash Volume|GRFS - Company Liquid Assets|ADPT (Adaptive Biotechnologies Inc.) - Company Cash Volume|CLDX: Company Cash Balance|Company Cash Funds Aurinia Pharmaceuticals Inc. (AUPH)|Company Cash Funds BCRX (BioCryst Pharmaceuticals Inc)|Company Cash Volume VERA (Vera Corp)|Company Total Cash Amount DNTH (Dianthus Therapeutics)|PHVS - Company Cash Funds|ABCL: Company Cash Funds|TRML: Company Cash Volume|Company Cash on Hand Precigen, Inc.|Company Cash on Hand PHAR|Nektar Therapeutics - Company Total Cash Volume|Company Cash Funds Upstream Bio Corp (UPB)|Company Cash on Hand Zenas Biopharma ZBIO|Company Cash Funds Immunome Bio IMNM|GOSS: Company Cash and Cash Equivalents|SEPN - Company Cash Funds|PVLA - Company Cash Volume|SVRA: Company Cash Volume|RIGL - Company Liquid Assets|ANAB (AnaptysBio Inc) - Company Cash Volume|Company Cash on Hand Astria Corp (ATXS)|Company Cash Volume ENGN|Company Liquid Assets rapt.com|Company Cash Volume JBIO (Aerovate Therapeutics Inc)|Company Liquid Assets Aclaris Therapeutics, Inc. (ACRS)|KYTX - Company Cash Funds|Company Liquid Assets Tiziana Life Sciences TLSA|CABA: Company Cash Volume|Company Cash and Cash Equivalents VTYX|Company Cash on Hand THTX|Company Cash Volume Avalo Therapeutics Inc.|Company Cash Funds Eledon (ELDN)|Company Cash Volume Agenus Inc (AGEN)|Company Cash Volume CLYM (climbbio.com)|ZURA - Company Cash on Hand|atyrpharma.com - Company Cash Volume|ADAG (adagene.com) - Company Cash and Cash Equivalents|IMA (Ikena Oncology) - Company Cash on Hand|Company Cash on Hand Shattuck Labs Inc|EQ (Equillium Inc) - Company Cash Volume|CNTB: Company Cash Balance|Company Cash Volume IMUX|ATRA (Atara Biotherapeutics, Inc.) - Company Cash Balance|Company Cash Volume IFRX (inflarx.de)|X4 Pharmaceuticals - Company Cash Funds|Adicet Bio, Inc. - Company Cash Volume|CELU (celularity.com) - Company Cash and Cash Equivalents|INMB: Company Cash Volume|Barinthus Biotherapeutics PLC (BRNS) - Company Cash Volume|Company Cash Funds Kezar Life Sciences|Company Cash on Hand SAB Biotherapeutics (SABS)|Company Cash Funds Akari Therapeutics Plc (AKTX)|Company Cash on Hand Enlivex Therapeutics, Ltd. ENLV|Q32 Bio Inc. - Company Cash on Hand|GeoVax Labs (GOVX) - Company Cash Reserve|edesabiotech.com - Company Cash Volume|Company Liquid Assets iBio Corp IBIO|CARM: Company Cash Volume|xtlbio.com (XTLB) - Company Cash Volume|BOLT (Bolt Biotherapeutics) - Company Cash Volume|Company Cash on Hand HCW Biologics (HCWB)|Company Cash on Hand APVO (Aptevo Therapeutics)|AIM - Company Cash Reserve|Aditxt - Company Cash on Hand|Company Cash Position gribio.com|XRTX: Company Cash on Hand|Company Cash Balance HIND (Vyome Holdings)|REVB (Revelation Bio) - Company Cash on Hand|Indaptus Corp (INDP) - Company Cash Volume|Company Cash Funds scinai.com|Company Cash on Hand CalciMedica, Inc. (CALI)|Company Cash Funds Affimed NV (AFMD)|Company Cash Funds ALLK (Allakos Inc)|Company Cash Funds HOOKIPA Pharma, Inc. HOOK|Company Liquid Assets IGM Bio (IGMS)|iTeos Pharma - Company Cash Volume|Company Liquid Assets oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Company Cash Funds|Company Cash and Cash Equivalents THRD